When to Reevaluate Progress Reevaluation is a normal and expected part of medically supervised semaglutide care
This foundational in vivo evidence has driven an expanding research programme using FOXO4-DRI as a molecular tool across multiple tissues and disease contexts
Worsening of diabetic retinopathy seems to be related particularly to rapid glycaemic improvement [80]
Fatigue accompanied by other concerning symptoms including: Persistent dizziness, lightheadedness, or fainting Rapid or irregular heartbeat Shortness of breath or chest pain Severe or unrelenting nausea and vomiting Inability to keep down food or fluids for more than 24 hours Dark urine, markedly reduced urination, or swelling (signs of dehydration or kidney problems) Yellowing of skin or eyes Severe abdominal pain Mood changes, depression, or difficulty concentrating Signs of potential complications require immediate attention: Stop the medication and seek urgent medical care if you experience severe abdominal pain (especially radiating to the back) which could suggest pancreatitis Stop the medication and seek urgent care if you develop symptoms of severe allergic reaction (rash, itching, swelling, severe dizziness, trouble breathing) Symptoms suggesting gallbladder disease (right upper abdominal pain, especially after eating) Hypoglycemia in patients taking diabetes medications (shakiness, sweating, confusion) Inability to meet nutritional needs despite best efforts, or unintentional weight loss exceeding recommended rates (generally more than 1-2 pounds per week after the initial period)
Mar 2008;42(3):233-8
Crystal formation in supposedly reconstituted solutions indicates the peptide has come out of solution
